Patients as partners: how engagement improves clinical research

Research about patients works better with patients. Patient and public involvement (PPI) — engaging patients as advisors and partners in designing, conducting and communicating research — has moved from principle to evidence-supported practice. A 2023 systematic review in Health Expectations synthesised the field’s experience: involvement brings benefits for both public contributors and researchers, from improved relevance and quality to empowerment and better dissemination, alongside honest challenges of time, resources and communication that good planning addresses.^[1]

Where partnership pays off

• Questions worth asking. Patients reshape priorities toward outcomes that matter in lived experience — sometimes quality of life over surrogate markers.
• Protocols people can live with. Visit burden, consent clarity and practical logistics improve when reviewed by those who would experience them; recruitment and retention follow.
• Communication that lands. Lay summaries and results-sharing designed with patients actually reach and respect their audience.
• Trust that compounds. Visible partnership strengthens the credibility on which all research participation rests.

Doing it genuinely

Tokenism is the failure mode; structure is the cure. Effective teams involve patients early enough to change decisions, prepare and remunerate contributors properly, and close the loop by showing what changed because of their input. Like any competence, partnership improves with training and reflection on both sides.

From advocacy to architecture

Patients forced their way into research governance before they were invited. HIV activists in the late 1980s and 1990s — educated, organised and unwilling to wait — changed trial designs, accelerated access pathways and permanently altered the assumption that research is done on rather than with people. Breast cancer and rare-disease communities carried the model forward, building registries, funding science and sitting on advisory boards. What began as protest matured into architecture: public involvement expectations in national research systems, patient representatives inside regulatory committee rooms, and funders asking every applicant the once-radical question — how were patients involved in shaping this study?

Doing engagement that changes the science

The difference between involvement that decorates and involvement that improves is method:

• Early enough to matter. Patients consulted after the protocol is final can only bless it; involved at the question-framing stage, they redirect studies toward outcomes that matter and designs people can live with.
• Partnership with infrastructure. Training for patient partners, fair compensation, accessible materials and named staff time — the practical scaffolding that converts good intentions into working relationships.
• Burden reviewed by the people who bear it. Visit schedules, procedures and diaries stress-tested by patients routinely reveal retention problems no investigator anticipated.
• Plain-language accountability. Results returned to participants and communities as a default courtesy — increasingly a formal expectation in European trials.
• Influence documented. Recording what changed because of patient input makes engagement auditable — and reveals, consistently, that it changes substantive things: endpoints, eligibility, consent clarity, feasibility.

Looking ahead

The frontier is moving from involvement in single studies toward partnership in research systems — patients co-governing registries, platforms and data spaces, and patient-generated evidence entering assessment dossiers. Engagement skill is accordingly becoming a professional competence with its own methods literature, not a matter of temperament. Research teams that learn it early report the same discovery the pioneers made: engaged patients do not slow science down — they stop it from answering the wrong questions.

Where EUSTM fits

The EUSTM Academy’s Professional Certification in Clinical Research (PCCR) embeds patient-centred design in professional competence, while the EUSTM Consortium connects institutions exchanging exactly this kind of good practice internationally.

Disclaimer. This Expert Insight is provided by EUSTM for general informational and educational purposes only. It does not constitute medical, clinical, legal, regulatory or other professional advice, and it should not be relied upon as the basis for clinical, regulatory or business decisions. While care is taken in preparing this content, EUSTM makes no representation or warranty as to the accuracy, completeness or currency of any scientific, medical or other statements, and accepts no liability arising from the use of this content. Readers should consult the cited sources, the current official guidance of the relevant authorities and frameworks, and appropriately qualified professionals in their own jurisdiction. References to third-party organisations, publications or frameworks are for information only and do not imply affiliation or endorsement.

← All Expert Insights